Transmural heterogeneity of cellular level power output is reduced in human heart failure Journal Article

Local Library Link: Find It @ Loyola

Authors: Haynes, P.; Nava, K. E.; Lawson, B. A.; Chung, C. S.; Mitov, M. I.; Campbell, S. G.; Stromberg, A. J.; Sadayappan, S; Bonnell, M. R.; Hoopes, C. W.; Campbell, K. S.
Article Title: Transmural heterogeneity of cellular level power output is reduced in human heart failure
Abstract: Heart failure is associated with pump dysfunction and remodeling but it is not yet known if the condition affects different transmural regions of the heart in the same way. We tested the hypotheses that the left ventricles of non-failing human hearts exhibit transmural heterogeneity of cellular level contractile properties, and that heart failure produces transmural region-specific changes in contractile function. Permeabilized samples were prepared from the sub-epicardial, mid-myocardial, and sub-endocardial regions of the left ventricular free wall of non-failing (n=6) and failing (n=10) human hearts. Power, an in vitro index of systolic function, was higher in non-failing mid-myocardial samples (0.59+/-0.06muWmg(-1)) than in samples from the sub-epicardium (p=0.021) and the sub-endocardium (p=0.015). Non-failing mid-myocardial samples also produced more isometric force (14.3+/-1.33kNm(-2)) than samples from the sub-epicardium (p=0.008) and the sub-endocardium (p=0.026). Heart failure reduced power (p=0.009) and force (p=0.042) but affected the mid-myocardium more than the other transmural regions. Fibrosis increased with heart failure (p=0.021) and mid-myocardial tissue from failing hearts contained more collagen than matched sub-epicardial (p0.001) and sub-endocardial (p=0.043) samples. Power output was correlated with the relative content of actin and troponin I, and was also statistically linked to the relative content and phosphorylation of desmin and myosin light chain-1. Non-failing human hearts exhibit transmural heterogeneity of contractile properties. In failing organs, region-specific fibrosis produces the greatest contractile deficits in the mid-myocardium. Targeting fibrosis and sarcomeric proteins in the mid-myocardium may be particularly effective therapies for heart failure.
Journal Title: Journal of Molecular and Cellular Cardiology
Volume: 72
ISSN: 1095-8584; 0022-2828
Publisher: Unknown  
Journal Place: England
Date Published: 2014
Start Page: 1
End Page: 8
Language: eng
DOI/URL:

10.1016/j.yjmcc.2014.02.008
Notes: LR: 20150701; CI: Copyright (c) 2014; GR: HL090749/HL/NHLBI NIH HHS/United States; GR: P30 CA177558/CA/NCI NIH HHS/United States; GR: R01 HL090749/HL/NHLBI NIH HHS/United States; GR: TR000117/TR/NCATS NIH HHS/United States; GR: UL1 RR033173/RR/NCRR NIH HHS/United States; GR: UL1 TR000117/TR/NCATS NIH HHS/United States; JID: 0262322; 0 (Actins); 0 (Desmin); 0 (Myosin Light Chains); 0 (Troponin I); NIHMS569751; OID: NLM: NIHMS569751; OID: NLM: PMC4037376; OTO: NOTNLM; 2013/12/02 [received]; 2014/01/22 [revised]; 2014/02/11 [accepted]; 2014/02/20 [aheadofprint]; ppublish